Case Against Generic Paxil Sputters In Appeals Court

Law360, New York (June 23, 2006, 12:00 AM EDT) -- Apotex Corp., the maker of a generic version of Paxil, won two key appeals this week against the popular antidepressant drug’s maker, GlaxoSmithKline Plc., which has tried hard to keep generics off the market.

On Monday, the Supreme Court let stand a lower court ruling against patent protection for the active ingredient in Paxil, effectively ending Glaxo’s case. On Thursday, the Federal Circuit denied Glaxo’s request that the court rehear a separate patent case related to the process of making a Paxil tablet.

In the case...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.